247 related articles for article (PubMed ID: 38667331)
21. Determination of the Role of Fusobacterium Nucleatum in the Pathogenesis in and Out the Mouth.
Tefiku U; Popovska M; Cana A; Zendeli-Bedxeti L; Recica B; Spasovska-Gjorgovska A; Spasovski S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2020 Jun; 41(1):87-99. PubMed ID: 32573481
[TBL] [Abstract][Full Text] [Related]
22. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract][Full Text] [Related]
23. Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells.
Park JY; Lee TS; Noh EJ; Jang AR; Ahn JH; Kim DY; Jung DH; Song EJ; Lee YJ; Lee YJ; Lee SK; Park JH
Am J Reprod Immunol; 2021 Jul; 86(1):e13403. PubMed ID: 33580557
[TBL] [Abstract][Full Text] [Related]
24. Maternal oral origin of Fusobacterium nucleatum in adverse pregnancy outcomes as determined using the 16S-23S rRNA gene intergenic transcribed spacer region.
Gonzales-Marin C; Spratt DA; Allaker RP
J Med Microbiol; 2013 Jan; 62(Pt 1):133-144. PubMed ID: 23002071
[TBL] [Abstract][Full Text] [Related]
25.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
26. Clinical Significance of
Zhang N; Liu Y; Yang H; Liang M; Wang X; Wang M; Kong J; Yuan X; Zhou F
Pathol Oncol Res; 2021; 27():1609846. PubMed ID: 34305476
[TBL] [Abstract][Full Text] [Related]
27. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
28. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
[TBL] [Abstract][Full Text] [Related]
29. Acute chorioamnionitis at term caused by the oral pathogen Fusobacterium nucleatum.
Bohrer JC; Kamemoto LE; Almeida PG; Ogasawara KK
Hawaii J Med Public Health; 2012 Oct; 71(10):280-1. PubMed ID: 23115747
[TBL] [Abstract][Full Text] [Related]
30. Immunological Pathways Triggered by
de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
[No Abstract] [Full Text] [Related]
31. Evaluation of
Rutherford JT; Avad K; Dureja C; Norseeda K; Gc B; Wu C; Sun D; Hevener KE; Hurdle JG
ACS Infect Dis; 2024 May; 10(5):1612-1623. PubMed ID: 38597503
[No Abstract] [Full Text] [Related]
32. Fusobacterium nucleatum and cancer.
Alon-Maimon T; Mandelboim O; Bachrach G
Periodontol 2000; 2022 Jun; 89(1):166-180. PubMed ID: 35244982
[TBL] [Abstract][Full Text] [Related]
33. Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection.
Lin R; Han C; Ding Z; Shi H; He R; Liu J; Qian W; Zhang Q; Fu X; Deng X; Zhou S; Hou X
Cancer Lett; 2020 Dec; 495():165-179. PubMed ID: 32920199
[TBL] [Abstract][Full Text] [Related]
34. Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum.
Peluso EA; Scheible M; Ton-That H; Wu C
Curr Protoc Microbiol; 2020 Jun; 57(1):e104. PubMed ID: 32539234
[TBL] [Abstract][Full Text] [Related]
35.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
36. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
Liu Y; Baba Y; Ishimoto T; Tsutsuki H; Zhang T; Nomoto D; Okadome K; Yamamura K; Harada K; Eto K; Hiyoshi Y; Iwatsuki M; Nagai Y; Iwagami S; Miyamoto Y; Yoshida N; Komohara Y; Ohmuraya M; Wang X; Ajani JA; Sawa T; Baba H
Br J Cancer; 2021 Mar; 124(5):963-974. PubMed ID: 33299132
[TBL] [Abstract][Full Text] [Related]
37. Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization.
Ikegami A; Chung P; Han YW
Infect Immun; 2009 Jul; 77(7):3075-9. PubMed ID: 19398541
[TBL] [Abstract][Full Text] [Related]
38. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance.
Ye C; Liu X; Liu Z; Pan C; Zhang X; Zhao Z; Sun H
Cancer Biol Ther; 2024 Dec; 25(1):2306676. PubMed ID: 38289287
[No Abstract] [Full Text] [Related]
39. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.
Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299
[TBL] [Abstract][Full Text] [Related]
40. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
